Ten interactive dashboards spanning the full clinical intelligence stack, from post-market drug safety through targeted protein degradation competitive analysis, emerging drug signals, and pharma data management. Each dashboard connects live public data sources to purpose-built visualizations.
FDA FAERS Adverse Event Surveillance
Explore post-market drug safety signals from the FDA Adverse Event Reporting System. Understand which drugs generate the most reports, the breakdown of serious vs. non-serious events, and look up any drug's specific adverse event profile.
Phase Attrition & Therapeutic Area Trends
Visualize the full drug development landscape, from early Phase 1 dose-finding through pivotal Phase 3 trials. Track how many trials exist at each stage, how enrollment scales with phase, and how therapeutic area activity has shifted over the past 15 years.
Interactive Choropleth Across 180+ Countries
An interactive D3 choropleth map showing clinical trial density across every country in the world. Hover to inspect individual countries, see regional breakdowns, and understand the heavy concentration of trials in North America and Europe.
Trial Results, Publication Lag & Evidence Gaps
Connect trial registrations to their published outcomes. Measure how quickly results are published after trial completion, identify evidence gaps where trials completed without published results, and explore which sponsors have the strongest publication track records.
Potency Profiles, Selectivity & Compound Data
Dive into the molecular biology behind drug targets. Query ChEMBL for compound activity data, visualize potency distributions for any target, and surface UniProt protein annotations for the biological context behind clinical programs.
Targeted Protein Degradation: Companies vs. Targets
Interactive matrix mapping every TPD company against every clinical target: STAT6, IRAK4, IRF5, ER, AR, BTK, GSPT1, and more. Includes phase-by-phase status, deal flow, and Kymera's differentiation in immunology.
Competition, Success Prediction & Stealth Signals
Four intelligence pillars for drug development: competitive landscape mapping, success prediction, drug improvement opportunities, and stealth company detection from public registry, patent, and publication signals.
Upcoming Events for Public Biopharma
Track upcoming catalysts for public biopharma companies: Phase 3 data readouts, FDA decisions, trial initiations, and partnership activity. Identify companies with near-term news that could drive stock movement and new revenue.
AWS, Cheminformatics & Scientific Computing
Tool landscape for scientific informatics teams: AWS cloud services, cheminformatics (RDKit, Schrodinger), proteomics (AlphaFold, MaxQuant), genomics pipelines (GATK, nf-core), data engineering (Nextflow, Airflow), and lab informatics (Benchling, Dotmatics).
Pharma Data Tiers, Voice & Excel Integration
How specialized pharma systems combine public registries, private vaults, real-time voice intelligence, AI orchestration, and trusted Excel workflows. Covers the pharma data ecosystem from CDD Vault and Benchling to Veeva and Snowflake.